Get started
Live feed
·
NEWSReleasevia Quantisnow
Heat Biologics Inc. logo

Heat Biologics (nighthawk Biosciences) Announces That Its Elusys Therapeutics Subsidiary Has Executed A Contract To Deliver ANTHIM To The Canadian Government For C$7.9M

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Heat Biologics Inc. logo
HTBX
Heat Biologics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Follow HTBXFull HTBX profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HTBX (Heat Biologics Inc.) and more on Quantisnow.